MSN Laboratories Private Limited Sunitinib Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Sunitinib Export Records India — #4 Exporter, 42 Shipments, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sunitinib

India Pharmaceutical Trade Intelligence

$63.6M114 Suppliers76 CountriesHS 30049099

ExportsIndia → CANADA50.5%India → UNITED STATES38.4%

ImportsITALY → India$418.6M ISRAEL → India$1.4M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: TARO PHARMACEUTICALS

MSN Laboratories Private Limited — Sunitinib Exporter #4 | $1.0M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Sunitinib Exporter Profile

Indian Pharmaceutical Exporter · #4 for Sunitinib · $1.0M export value · DGFT Verified

MSN Laboratories Private Limited is the #4 Indian exporter of Sunitinib with $1.0M in export value and 42 verified shipments. MSN Laboratories Private Limited holds a 1.6% market share in Sunitinib exports across 5 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Sunitinib Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Sunitinib export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Sunitinib?

Country	Value	Shipments	Share
PERU	$212.1K	5	38.9%
UNITED STATES	$117.4K	4	21.5%
UNITED ARAB EMIRATES	$100.0K	2	18.3%
MALTA	$65.7K	21	12.0%

Who Are the Top Buyers of Sunitinib from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	MALTA	$195.0K	10
MSN LABS PERU SAC	PERU	$162.1K	4
WORLD HEALTH ORGANIZATION WAREHOUSE	UNITED ARAB EMIRATES	$100.0K	2
MSN LABORATORIES EUROPE LIMITED	UNITED KINGDOM	$18.8K	4
MSN LABORATORIES EUROPE LIMITED C	UNITED KINGDOM	$16.4K	2
PHARMADOX HEALTHCARE LIMITED	MALTA	$14.7K	6
MSN LABORATORIES EUROPE LIMITED .	UNITED KINGDOM	$14.6K	3
PHARMADOX HEALTHCARE LTD.,	MALTA	$11.8K	6
PHARMADOX HEALTHCARE LTD	MALTA	$11.5K	4
ARC PHARMA (UK) LIMITED	UNITED KINGDOM	$100	1

MSN Laboratories Private Limited supplies Sunitinib to 10 buyers globally. The largest buyer is TO THE ORDER OF (MALTA), followed by MSN LABS PERU SAC (PERU) and WORLD HEALTH ORGANIZATION WAREHOUSE (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sunitinib Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
SUNITINIB 50 MG 1X28S AURUGULF AE	$50.0K	1
SUNITINIB 12 5MG 1X28S AURUGULF AE	$50.0K	1
SUTYKA 25MG (SUNITINIB 2X14 S) MSN -PE	$50.0K	1
SUTYKA 25MGSUNITINIB 2x14's MSN -PE	$50.0K	1
Sutkya 25 mg (Sunitinib 2x14's) MSN-PE BATCH NO:CRE11042A	$50.0K	1
SUTYAKA 25 MG (SUNITINIB 2X14"S)MSN ( QTY: 2033 PAC AS PER INVOICE )	$50.0K	1
SUNITINIB MALATE CAPSULES 37.50MG 28'S	$50.0K	1
SUNITINIB MALATE CAPSULES 25MG 28'S	$43.8K	1
SUNITINIB MALATE CAPSULES 50MG 28'S	$17.2K	1
SUNITINIB HARD CAPSULE 12.5MG 28S	$16.4K	2

MSN Laboratories Private Limited exports 39 distinct Sunitinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SUNITINIB 50 MG 1X28S AURUGULF AE with 1 shipments worth $50.0K.

How Does MSN Laboratories Private Limited Compare to Nearest Sunitinib Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$6.9M	138	7	$50.0K
4	MSN LABORATORIES PRIVATE LIMITED ★	$1.0M	42	5	$23.9K
3	SUN PHARMACEUTICAL INDUSTRIES LTD	$450.0K	9	1	$50.0K
6	JODAS EXPOIM PRIVATE LIMITED	$428.2K	16	2	$26.8K

MSN Laboratories Private Limited ranks #4 among 114 Indian Sunitinib exporters. Average shipment value of $23.9K compared to the market average of $87.1K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD.

Which Indian Ports Ship Sunitinib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	177	29.2%
SAHAR AIR	118	19.4%
DELHI AIR	40	6.6%
DELHI AIR CARGO ACC (INDEL4)	38	6.3%
Bombay Air Cargo	25	4.1%
HYDERABAD ACC (INHYD4)	22	3.6%
HYDERABAD AIR	16	2.6%
NHAVA SHEVA SEA (INNSA1)	15	2.5%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Sunitinib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sunitinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 42 individual customs records matching MSN Laboratories Private Limited exporting Sunitinib, covering 39 formulations to 5 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 76+ countries, 188+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sunitinib

Sunitinib

MSN Laboratories Private Limited — Sunitinib Exporter Profile

MSN Laboratories Private Limited — Sunitinib Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Sunitinib?

Who Are the Top Buyers of Sunitinib from MSN Laboratories Private Limited?

What Is India's Total Sunitinib Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Sunitinib Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Sunitinib Exporters?

What Sunitinib Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Sunitinib to Key Markets

United States — FDA

How Does MSN Laboratories Private Limited Compare to Nearest Sunitinib Exporters?

Which Indian Ports Ship Sunitinib Exports?

What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Sunitinib Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sunitinib Export Data from MSN Laboratories Private Limited

Sunitinib Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source